PFO

Active Implantable Bone Conduction Hearing System

Product code
PFO
Device name
Active Implantable Bone Conduction Hearing System
Device class
Class 2
21 CFR
21 CFR 874.3340
Medical specialty
Ear, Nose, Throat
Marketing pathway
510(K)
Flag
Implant
510(k) clearances (last 3 years)
3
Summaries archived here
2 (direct download)
510(k) clearances (all years, FDA)
12 (all years; only the last 3 years are listed here)

FDA classification definition

An active implantable bone conduction hearing system is a prescription device consisting of an implanted transducer, implanted electronics components, and an audio processor. The active implantable bone conduction hearing system is intended to compensate for conductive or mixed hearing losses by conveying amplified acoustic signals to the cochlea via mechanical vibrations on the skull bone.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (3)

Last three years. Most recent: 2026-07-10.

NumberDecision dateApplicantDevice nameSummary
K2609022026-07-10Cochlear AmericasCochlear™ Osia® 3(I) Sound Processor;Cochlear™ Osia®…FDA
K2406142024-07-10Oticon Medical ABSentio Ti Implant Kit; Sentio 1 Mini; Genie Medical …PDF
K2401552024-04-18Cochlear AmericasCochlear Osia SystemPDF

2 summaries are archived here for direct download.

Official FDA classification page: PFO
Classification and pathway per current FDA publications. Data from openFDA (CC0).